Immunity 12 years after alemtuzumab in RA: CD5+ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions